Overview

A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled, multi-center clinical trial will evaluate the effect and security of steroids therapy for patients of IgA nephropathy with active pathological changes,including crescents,necrosis and microthrombus.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate